Search results for

Hisao Yamasaki explains why compulsory licensing should be used as a last resort and why he helped launch the Open COVID-19 Declaration

In an interview, anti-pay-for-delay champion Xavier Becerra says he hopes the new government will aid march-ins and monitoring of Operation Warp Speed

A regular column devoted to IP curiosities and controversies, named in honour of John of Utynam

Sites selling counterfeits of five luxury goods attract at least half of the traffic the brands' legitimate sites attract, according to a study

Proposed legislation in the US House of Representatives seeks to limit patent term extension for pharmaceutical products in a way that pharma innovators say would stifle innovation and not solve potential drug pricing problems

Nell Greenhouse of Kangxin evaluates different ways to enforce IP rights in China, including administrative actions, mediation, cease and desist letters and customs recordal

Although the USPTO has released guidelines trying to clarify SCOTUS’s Booking.com ruling, generic.com brands will still be refused, say lawyers

In-house counsel are debating which products may not even need IP protection as they cautiously eye the post-COVID world

The enforcement of trademark infringement crimes is not ex-officio in Turkey. In other words, trademark owners have to file a criminal complaint to start criminal IP proceedings for each and every case. Thus trademark owners have to take into consideration beforehand, all possible risks that might occur in a worst case scenario, especially counterclaims which could include damages figures put forward by infringers if no fake products can be seized during an actual raid or even worse, if original products are seized during a raid instead of fakes.

Lawyers from the agricultural sector say that in-fighting over CRISPR patents and a CJEU ruling that crops derived from this technology are genetically modified organisms make patent pools unlikely